258 related articles for article (PubMed ID: 38514625)
21. Multiple myeloma: lusting for NF-kappaB.
Gilmore TD
Cancer Cell; 2007 Aug; 12(2):95-7. PubMed ID: 17692798
[TBL] [Abstract][Full Text] [Related]
22. Role for protein kinase Ctheta (PKCtheta) in TCR/CD28-mediated signaling through the canonical but not the non-canonical pathway for NF-kappaB activation.
Li Y; Sedwick CE; Hu J; Altman A
J Biol Chem; 2005 Jan; 280(2):1217-23. PubMed ID: 15536066
[TBL] [Abstract][Full Text] [Related]
23. IΚΚε cooperates with either MEK or non-canonical NF-kB driving growth of triple-negative breast cancer cells in different contexts.
House CD; Grajales V; Ozaki M; Jordan E; Wubneh H; Kimble DC; James JM; Kim MK; Annunziata CM
BMC Cancer; 2018 May; 18(1):595. PubMed ID: 29801480
[TBL] [Abstract][Full Text] [Related]
24. NF-kappaB signalling proteins p50/p105, p52/p100, RelA, and IKKepsilon are over-expressed in oesophageal squamous cell carcinomas.
Kang MR; Kim MS; Kim SS; Ahn CH; Yoo NJ; Lee SH
Pathology; 2009; 41(7):622-5. PubMed ID: 20001340
[TBL] [Abstract][Full Text] [Related]
25. Fbxw7α- and GSK3-mediated degradation of p100 is a pro-survival mechanism in multiple myeloma.
Busino L; Millman SE; Scotto L; Kyratsous CA; Basrur V; O'Connor O; Hoffmann A; Elenitoba-Johnson KS; Pagano M
Nat Cell Biol; 2012 Mar; 14(4):375-85. PubMed ID: 22388891
[TBL] [Abstract][Full Text] [Related]
26. CDK12-mediated transcriptional regulation of noncanonical NF-κB components is essential for signaling.
Henry KL; Kellner D; Bajrami B; Anderson JE; Beyna M; Bhisetti G; Cameron T; Capacci AG; Bertolotti-Ciarlet A; Feng J; Gao B; Hopkins B; Jenkins T; Li K; May-Dracka T; Murugan P; Wei R; Zeng W; Allaire N; Buckler A; Loh C; Juhasz P; Lucas B; Ennis KA; Vollman E; Cahir-McFarland E; Hett EC; Ols ML
Sci Signal; 2018 Jul; 11(541):. PubMed ID: 30065029
[TBL] [Abstract][Full Text] [Related]
27. Constitutively active canonical NF-κB pathway induces severe bone loss in mice.
Otero JE; Chen T; Zhang K; Abu-Amer Y
PLoS One; 2012; 7(6):e38694. PubMed ID: 22685599
[TBL] [Abstract][Full Text] [Related]
28. The impact of NF-κB signaling on pathogenesis and current treatment strategies in multiple myeloma.
Vrábel D; Pour L; Ševčíková S
Blood Rev; 2019 Mar; 34():56-66. PubMed ID: 30501907
[TBL] [Abstract][Full Text] [Related]
29. Alternative pathways of NF-kappaB activation: a double-edged sword in health and disease.
Xiao G; Rabson AB; Young W; Qing G; Qu Z
Cytokine Growth Factor Rev; 2006 Aug; 17(4):281-93. PubMed ID: 16793322
[TBL] [Abstract][Full Text] [Related]
30. [Noncanonical NF-κB pathway and hematological malignancies].
Wang WJ; Sun AN; Guo F
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Aug; 18(4):1069-73. PubMed ID: 20723331
[TBL] [Abstract][Full Text] [Related]
31. Mechanisms and consequences of constitutive NF-κB activation in B-cell lymphoid malignancies.
Nagel D; Vincendeau M; Eitelhuber AC; Krappmann D
Oncogene; 2014 Dec; 33(50):5655-65. PubMed ID: 24469030
[TBL] [Abstract][Full Text] [Related]
32. PSMB4 promotes multiple myeloma cell growth by activating NF-κB-miR-21 signaling.
Zheng P; Guo H; Li G; Han S; Luo F; Liu Y
Biochem Biophys Res Commun; 2015 Mar; 458(2):328-33. PubMed ID: 25656574
[TBL] [Abstract][Full Text] [Related]
33. Biologic sequelae of I{kappa}B kinase (IKK) inhibition in multiple myeloma: therapeutic implications.
Hideshima T; Chauhan D; Kiziltepe T; Ikeda H; Okawa Y; Podar K; Raje N; Protopopov A; Munshi NC; Richardson PG; Carrasco RD; Anderson KC
Blood; 2009 May; 113(21):5228-36. PubMed ID: 19270264
[TBL] [Abstract][Full Text] [Related]
34. Importin β1 mediates nuclear factor-κB signal transduction into the nuclei of myeloma cells and affects their proliferation and apoptosis.
Yan W; Li R; He J; Du J; Hou J
Cell Signal; 2015 Apr; 27(4):851-9. PubMed ID: 25643631
[TBL] [Abstract][Full Text] [Related]
35. Alternative NF-κB signaling promotes colorectal tumorigenesis through transcriptionally upregulating Bcl-3.
Tao Y; Liu Z; Hou Y; Wang S; Liu S; Jiang Y; Tan D; Ge Q; Li C; Hu Y; Liu Z; Chen X; Wang Q; Wang M; Zhang X
Oncogene; 2018 Nov; 37(44):5887-5900. PubMed ID: 29973688
[TBL] [Abstract][Full Text] [Related]
36. Classical and/or alternative NF-kappaB pathway activation in multiple myeloma.
Demchenko YN; Glebov OK; Zingone A; Keats JJ; Bergsagel PL; Kuehl WM
Blood; 2010 Apr; 115(17):3541-52. PubMed ID: 20053756
[TBL] [Abstract][Full Text] [Related]
37. Chromatin-based, in cis and in trans regulatory rewiring underpins distinct oncogenic transcriptomes in multiple myeloma.
Alvarez-Benayas J; Trasanidis N; Katsarou A; Ponnusamy K; Chaidos A; May PC; Xiao X; Bua M; Atta M; Roberts IAG; Auner HW; Hatjiharissi E; Papaioannou M; Caputo VS; Sudbery IM; Karadimitris A
Nat Commun; 2021 Sep; 12(1):5450. PubMed ID: 34521827
[TBL] [Abstract][Full Text] [Related]
38. A fourth IkappaB protein within the NF-kappaB signaling module.
Basak S; Kim H; Kearns JD; Tergaonkar V; O'Dea E; Werner SL; Benedict CA; Ware CF; Ghosh G; Verma IM; Hoffmann A
Cell; 2007 Jan; 128(2):369-81. PubMed ID: 17254973
[TBL] [Abstract][Full Text] [Related]
39. NF-kappaB2 processing and p52 nuclear accumulation after androgenic stimulation of LNCaP prostate cancer cells.
Lessard L; Saad F; Le Page C; Diallo JS; Péant B; Delvoye N; Mes-Masson AM
Cell Signal; 2007 May; 19(5):1093-100. PubMed ID: 17292587
[TBL] [Abstract][Full Text] [Related]
40. Opposing roles of Nfkb2 gene products p100 and p52 in the regulation of breast cancer stem cells.
Yeo SK; French R; Spada F; Clarkson R
Breast Cancer Res Treat; 2017 Apr; 162(3):465-477. PubMed ID: 28190248
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
